{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:17:16Z","timestamp":1789708636768,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Regional Development Funds, European Union","award":["EFA031\/01 (NEURO-COOP)"],"award-info":[{"award-number":["EFA031\/01 (NEURO-COOP)"]}]},{"name":"Regional Development Funds, European Union","award":["EFA031\/01 (NEURO-COOP)"],"award-info":[{"award-number":["EFA031\/01 (NEURO-COOP)"]}]},{"name":"Regional Development Funds, European Union","award":["EFA031\/01 (NEURO-COOP)"],"award-info":[{"award-number":["EFA031\/01 (NEURO-COOP)"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n, Agencia Estatal de Investigaci\u00f3n, Spain","award":["PID2021-1222010B-C22"],"award-info":[{"award-number":["PID2021-1222010B-C22"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n, Agencia Estatal de Investigaci\u00f3n, Spain","award":["PID2020-117465GB-I00"],"award-info":[{"award-number":["PID2020-117465GB-I00"]}]},{"name":"Ministerio de Ciencia e Innovaci\u00f3n, Agencia estatal de Investigaci\u00f3n, Spain","award":["PID2021-122201OB-C21"],"award-info":[{"award-number":["PID2021-122201OB-C21"]}]},{"name":"Joint Program in Neurodegenerative Research, JPND, European Union","award":["JPND-2021-650-130"],"award-info":[{"award-number":["JPND-2021-650-130"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["AC21_2\/00024"],"award-info":[{"award-number":["AC21_2\/00024"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2021-001136-S"],"award-info":[{"award-number":["CEX2021-001136-S"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02175-w","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:50:00Z","timestamp":1764766200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spontaneous generation of diverse recombinant prion strains: sulfated glycan cofactors facilitate strain emergence but do not determine specific strain properties"],"prefix":"10.1186","volume":"13","author":[{"given":"Nuria L.","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasier","family":"Era\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge M.","family":"Charco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Parga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"D\u00edaz-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"Giler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariv\u00ed","family":"Geijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas R.","family":"Requena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Castilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB, Prions (1998) Proc Natl Acad Sci 95:13363\u201313383","journal-title":"Proc Natl Acad Sci"},{"key":"2175_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1152\/physrev.00006.2009","volume":"89","author":"A Aguzzi","year":"2009","unstructured":"Aguzzi A, Calella AM (2009) Prions: protein aggregation and infectious diseases. Physiol Rev 89:1105\u20131152","journal-title":"Physiol Rev"},{"key":"2175_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"2175_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.pmbts.2017.06.004","volume":"150","author":"NA Mabbott","year":"2017","unstructured":"Mabbott NA (2017) Chapter ten immunology of prion protein and prions. Prog Mol Biol Transl Sci 150:203\u2013240","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2175_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1750-3639.1991.tb00673.x","volume":"1","author":"SB Prusiner","year":"1991","unstructured":"Prusiner SB, DeArmond SJ (1991) Molecular biology and pathology of scrapie and the prion diseases of humans. Brain Pathol 1:297\u2013310","journal-title":"Brain Pathol"},{"key":"2175_CR6","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1016\/j.molcel.2021.08.011","volume":"81","author":"A Kraus","year":"2021","unstructured":"Kraus A, Hoyt F, Schwartz CL, Hansen B, Artikis E, Hughson AG et al (2021) High-resolution structure and strain comparison of infectious mammalian prions. Mol Cell 81:4540\u20134551e6","journal-title":"Mol Cell"},{"key":"2175_CR7","doi-asserted-by":"publisher","first-page":"e1010947","DOI":"10.1371\/journal.ppat.1010947","volume":"18","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Alam P, Artikis E, Schwartz CL, Hughson AG, Race B et al (2022) Cryo-EM of prion strains from the same genotype of host identifies conformational determinants. PLOS Pathog 18:e1010947","journal-title":"PLOS Pathog"},{"key":"2175_CR8","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1038\/s41467-022-30458-6","volume":"13","author":"F Hoyt","year":"2022","unstructured":"Hoyt F, Standke HG, Artikis E, Schwartz CL, Hansen B, Li K et al (2022) Cryo-EM structure of anchorless RML prion reveals variations in shared motifs between distinct strains. Nat Commun 13:4005","journal-title":"Nat Commun"},{"key":"2175_CR9","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1038\/s41467-022-30457-7","volume":"13","author":"SW Manka","year":"2022","unstructured":"Manka SW, Zhang W, Wenborn A, Betts J, Joiner S, Saibil HR et al (2022) 2.7 \u00c5 cryo-EM structure of ex vivo RML prion fibrils. Nat Commun 13:4004","journal-title":"Nat Commun"},{"key":"2175_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41589-022-01229-7","volume":"19","author":"SW Manka","year":"2023","unstructured":"Manka SW, Wenborn A, Betts J, Joiner S, Saibil HR, Collinge J et al (2023) A structural basis for prion strain diversity. Nat Chem Biol 19:607\u2013613","journal-title":"Nat Chem Biol"},{"key":"2175_CR11","first-page":"337","volume":"93","author":"SB Prusiner","year":"1998","unstructured":"Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion Protein Biology Cell 93:337\u2013348","journal-title":"Prion Protein Biology Cell"},{"key":"2175_CR12","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.1073\/pnas.94.25.13452","volume":"94","author":"DG Donne","year":"1997","unstructured":"Donne DG, Viles JH, Groth D, Mehlhorn I, James TL, Cohen FE et al (1997) Structure of the Recombinant full-length hamster prion protein PrP(29\u2013231): the N terminus is highly flexible. Proc Natl Acad Sci 94:13452\u201313457","journal-title":"Proc Natl Acad Sci"},{"key":"2175_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0014-5793(97)00921-6","volume":"413","author":"S Hornemann","year":"1997","unstructured":"Hornemann S, Korth C, Oesch B, Riek R, Wider G, W\u00fcthrich K et al (1997) Recombinant full-length murine prion protein, mPrP(23\u2013231): purification and spectroscopic characterization. FEBS Lett 413:277\u2013281","journal-title":"FEBS Lett"},{"key":"2175_CR14","doi-asserted-by":"crossref","unstructured":"Prion (2024) Conference Abstracts. Prion. 2024;18:1\u201347","DOI":"10.1080\/19336896.2024.2424058"},{"key":"2175_CR15","doi-asserted-by":"publisher","first-page":"14421","DOI":"10.1021\/jp9050098","volume":"113","author":"EP O\u2019Brien","year":"2009","unstructured":"O\u2019Brien EP, Okamoto Y, Straub JE, Brooks BR, Thirumalai D (2009) Thermodynamic perspective on the Dock\u2009\u2013\u2009Lock growth mechanism of amyloid fibrils. J Phys Chem B 113:14421\u201314430","journal-title":"J Phys Chem B"},{"key":"2175_CR16","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1073\/pnas.95.8.4224","volume":"95","author":"JI Guijarro","year":"1998","unstructured":"Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM (1998) Amyloid fibril formation by an SH3 domain. Proc Natl Acad Sci 95:4224\u20134228","journal-title":"Proc Natl Acad Sci"},{"key":"2175_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/2151043a0","volume":"215","author":"GRIFFITH JS","year":"1967","unstructured":"GRIFFITH JS (1967) Nature of the scrapie agent: Self-replication and scrapie. Nature 215:1043\u20131044","journal-title":"Nature"},{"key":"2175_CR18","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1073\/pnas.90.13.5959","volume":"90","author":"JH Come","year":"1993","unstructured":"Come JH, Fraser PE, Lansbury PT (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci 90:5959\u20135963","journal-title":"Proc Natl Acad Sci"},{"key":"2175_CR19","first-page":"673","volume":"305","author":"G Legname","year":"2004","unstructured":"Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, DeArmond SJ et al (2004) Synth Mammalian Prions Sci 305:673\u2013676","journal-title":"Synth Mammalian Prions Sci"},{"key":"2175_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41594-020-0441-5","volume":"27","author":"L-Q Wang","year":"2020","unstructured":"Wang L-Q, Zhao K, Yuan H-Y, Wang Q, Guan Z, Tao J et al (2020) Cryo-EM structure of an amyloid fibril formed by full-length human prion protein. Nat Struct Mol Biol 27:598\u2013602","journal-title":"Nat Struct Mol Biol"},{"key":"2175_CR21","doi-asserted-by":"publisher","first-page":"eabg9676","DOI":"10.1126\/sciadv.abg9676","volume":"7","author":"L-Q Wang","year":"2021","unstructured":"Wang L-Q, Zhao K, Yuan H-Y, Li X-N, Dang H-B, Ma Y et al (2021) Genetic prion disease\u2013related mutation E196K displays a novel amyloid fibril structure revealed by cryo-EM. Sci Adv 7:eabg9676","journal-title":"Sci Adv"},{"key":"2175_CR22","doi-asserted-by":"publisher","first-page":"9741","DOI":"10.1073\/pnas.0702662104","volume":"104","author":"NR Deleault","year":"2007","unstructured":"Deleault NR, Harris BT, Rees JR, Supattapone S (2007) Formation of native prions from minimal components in vitro. Proc Natl Acad Sci 104:9741\u20139746","journal-title":"Proc Natl Acad Sci"},{"key":"2175_CR23","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1126\/science.1183748","volume":"327","author":"F Wang","year":"2010","unstructured":"Wang F, Wang X, Yuan C-G, Ma J (2010) Generating a prion with bacterially expressed Recombinant prion protein. Science 327:1132\u20131135","journal-title":"Science"},{"key":"2175_CR24","doi-asserted-by":"publisher","unstructured":"Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J et al (2012) Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc Natl Acad Sci [Internet]. ;109:E1938\u201346. Available from: http:\/\/www.pnas.org\/cgi\/doi\/https:\/\/doi.org\/10.1073\/pnas.1206999109","DOI":"10.1073\/pnas.1206999109"},{"key":"2175_CR25","doi-asserted-by":"crossref","unstructured":"Supattapone S (2014) Synthesis of High Titer Infectious Prions with Cofactor Molecules*. J Biol Chem [Internet]. ;289:19850\u20134. Available from: http:\/\/pubmed.gov\/24860097","DOI":"10.1074\/jbc.R113.511329"},{"key":"2175_CR26","doi-asserted-by":"publisher","unstructured":"Miller MB, Wang DW, Wang F, Noble GP, Ma J, Woods VL et al (2013) Cofactor Molecules Induce Structural Transformation during Infectious Prion Formation. Structure [Internet]. ;21:2061\u20138. Available from: https:\/\/doi.org\/10.1016\/j.str.2013.08.025","DOI":"10.1016\/j.str.2013.08.025"},{"key":"2175_CR27","doi-asserted-by":"publisher","unstructured":"Era\u00f1a H, Charco JM, Bari MAD, D\u00edaz-Dom\u00ednguez CM, L\u00f3pez-Moreno R, Vidal E et al (2019) Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies. PLoS Pathog [Internet]. ;15:e1008117. Available from: https:\/\/doi.org\/10.1371\/journal.ppat.1008117","DOI":"10.1371\/journal.ppat.1008117"},{"key":"2175_CR28","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Borges N, Bari MAD, Era\u00f1a H, S\u00e1nchez-Mart\u00edn M, Pirisinu L, Parra B et al (2017) Cofactors influence the biological properties of infectious recombinant prions. Acta Neuropathol [Internet]. ;135:179\u201399. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00401-017-1782-y","DOI":"10.1007\/s00401-017-1782-y"},{"key":"2175_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-023-01640-8","volume":"11","author":"H Era\u00f1a","year":"2023","unstructured":"Era\u00f1a H, D\u00edaz-Dom\u00ednguez CM, Charco JM, Vidal E, Gonz\u00e1lez-Miranda E, P\u00e9rez-Castro MA et al (2023) Understanding the key features of the spontaneous formation of Bona Fide prions through a novel methodology that enables their swift and consistent generation. Acta Neuropathol Commun 11:145","journal-title":"Acta Neuropathol Commun"},{"key":"2175_CR30","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/s41467-024-46360-2","volume":"15","author":"H Era\u00f1a","year":"2024","unstructured":"Era\u00f1a H, Sampedro-Torres-Quevedo C, Charco JM, D\u00edaz-Dom\u00ednguez CM, Peccati F, San-Juan-Ansoleaga M et al (2024) A protein misfolding shaking Amplification-based method for the spontaneous generation of hundreds of Bona Fide prions. Nat Commun 15:2112","journal-title":"Nat Commun"},{"key":"2175_CR31","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Borges N, Era\u00f1a H, Elezgarai SR, Harrathi C, Venegas V, Castilla J, Prions (2017) Methods and Protocols. Methods Mol Biol [Internet]. ;1658:205\u201316. Available from: http:\/\/pubmed.gov\/28861792","DOI":"10.1007\/978-1-4939-7244-9_15"},{"key":"2175_CR32","doi-asserted-by":"publisher","first-page":"e1012890","DOI":"10.1371\/journal.ppat.1012890","volume":"21","author":"M\u00c1 P\u00e9rez-Castro","year":"2025","unstructured":"P\u00e9rez-Castro M\u00c1, Era\u00f1a H, Vidal E, Charco JM, Lorenzo NL, Gon\u00e7alves-Anjo N et al (2025) Cofactors facilitate Bona Fide prion misfolding in vitro but are not necessary for the infectivity of Recombinant murine prions. PLOS Pathog 21:e1012890","journal-title":"PLOS Pathog"},{"key":"2175_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-022-01477-7","volume":"10","author":"E Vidal","year":"2022","unstructured":"Vidal E, S\u00e1nchez-Mart\u00edn MA, Era\u00f1a H, L\u00e1zaro SP, P\u00e9rez-Castro MA, Otero A et al (2022) Bona Fide atypical scrapie faithfully reproduced for the first time in a rodent model. Acta Neuropathol Commun 10:179","journal-title":"Acta Neuropathol Commun"},{"key":"2175_CR34","doi-asserted-by":"publisher","unstructured":"Aguilar-Calvo P, Sevillano AM, Bapat J, Soldau K, Sandoval DR, Altmeppen HC et al (2019) Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions. Acta Neuropathol [Internet]. ;139:527\u201346. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00401-019-02085-x","DOI":"10.1007\/s00401-019-02085-x"},{"key":"2175_CR35","doi-asserted-by":"publisher","unstructured":"V\u00e1zquez-Fern\u00e1ndez E, Alonso J, Pastrana MA, Ramos A, Stitz L, Vidal E et al (2012) Structural Organization of Mammalian Prions as Probed by Limited Proteolysis. Baskakov IV, editor. PLoS ONE [Internet]. ;7:e50111. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0050111","DOI":"10.1371\/journal.pone.0050111"},{"key":"2175_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.virusres.2015.03.008","volume":"207","author":"CJ Silva","year":"2015","unstructured":"Silva CJ, V\u00e1zquez-Fern\u00e1ndez E, Onisko B, Requena JR (2015) Proteinase K and the structure of prpsc: the good, the bad and the ugly. Virus Res 207:120\u2013126","journal-title":"Virus Res"},{"key":"2175_CR37","doi-asserted-by":"publisher","first-page":"e1006797","DOI":"10.1371\/journal.ppat.1006797","volume":"14","author":"AM Sevillano","year":"2018","unstructured":"Sevillano AM, Fern\u00e1ndez-Borges N, Younas N, Wang F, Elezgarai SR, Bravo S et al (2018) Recombinant PrPSc shares structural features with brain-derived prpsc: insights from limited proteolysis. PLoS Pathog 14:e1006797","journal-title":"PLoS Pathog"},{"key":"2175_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jmb.2008.06.070","volume":"382","author":"G Sajnani","year":"2008","unstructured":"Sajnani G, Pastrana MA, Dynin I, Onisko B, Requena JR (2008) Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry. J Mol Biol 382:88\u201398","journal-title":"J Mol Biol"},{"key":"2175_CR39","doi-asserted-by":"publisher","first-page":"38936","DOI":"10.1074\/jbc.M405468200","volume":"279","author":"G Zanusso","year":"2004","unstructured":"Zanusso G, Farinazzo A, Prelli F, Fiorini M, Gelati M, Ferrari S et al (2004) Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease Subtypes*. J Biol Chem 279:38936\u201338942","journal-title":"J Biol Chem"},{"key":"2175_CR40","doi-asserted-by":"publisher","first-page":"13434","DOI":"10.1021\/bi9610562","volume":"35","author":"DA Kocisko","year":"1996","unstructured":"Kocisko DA, Lansbury PT, Caughey B (1996) Partial unfolding and refolding of Scrapie-Associated prion protein: evidence for a critical 16-kDa C-Terminal domain \u2020. Biochemistry 35:13434\u201313442","journal-title":"Biochemistry"},{"key":"2175_CR41","doi-asserted-by":"publisher","first-page":"40429","DOI":"10.1074\/jbc.M308550200","volume":"278","author":"W-Q Zou","year":"2003","unstructured":"Zou W-Q, Capellari S, Parchi P, Sy M-S, Gambetti P, Chen SG (2003) Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob Disease*. J Biol Chem 278:40429\u201340436","journal-title":"J Biol Chem"},{"key":"2175_CR42","doi-asserted-by":"publisher","unstructured":"Weissmann C, Li J, Mahal SP, Browning S (2011) Prions on the move. EMBO Rep [Internet]. ;12:1109\u201317. Available from: https:\/\/doi.org\/10.1038\/embor.2011.192","DOI":"10.1038\/embor.2011.192"},{"key":"2175_CR43","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1111\/febs.17291","volume":"291","author":"H Rezaei","year":"2024","unstructured":"Rezaei H, Martin D, Herzog L, Reine F, Moreno AM, Moudjou M et al (2024) Species barrier as molecular basis for adaptation of synthetic prions with N-terminally truncated PrP. FEBS J 291:5051\u20135076","journal-title":"FEBS J"},{"key":"2175_CR44","doi-asserted-by":"crossref","unstructured":"Klimova N, Makarava N, Baskakov IV (2015) The diversity and relationship of prion protein self-replicating states. Virus Res [Internet]. ;207:113\u20139. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170214004067","DOI":"10.1016\/j.virusres.2014.10.002"},{"key":"2175_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00401-009-0633-x","volume":"119","author":"N Makarava","year":"2010","unstructured":"Makarava N, Kovacs GG, Bocharova O, Savtchenko R, Alexeeva I, Budka H et al (2010) Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119:177\u2013187","journal-title":"Acta Neuropathol"},{"key":"2175_CR46","doi-asserted-by":"publisher","unstructured":"Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG et al (2011) Genesis of Mammalian Prions: From Non-infectious Amyloid Fibrils to a Transmissible Prion Disease. Supattapone S, editor. PLoS Pathog [Internet]. 7:e1002419. Available from: https:\/\/doi.org\/10.1371\/journal.ppat.1002419","DOI":"10.1371\/journal.ppat.1002419"},{"key":"2175_CR47","doi-asserted-by":"publisher","unstructured":"Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC et al (2012) Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci. 109:8546\u201351. Available from: https:\/\/doi.org\/10.1073\/pnas.1204498109","DOI":"10.1073\/pnas.1204498109"},{"key":"2175_CR48","doi-asserted-by":"publisher","unstructured":"Timmes AG, Moore RA, Fischer ER, Priola SA (2013) Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity. Chiesa R, editor. PLoS ONE [Internet]. ;8:e71081. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0071081","DOI":"10.1371\/journal.pone.0071081"},{"key":"2175_CR49","doi-asserted-by":"publisher","first-page":"e1006491","DOI":"10.1371\/journal.ppat.1006491","volume":"13","author":"F Wang","year":"2017","unstructured":"Wang F, Wang X, Orr\u00fa CD, Groveman BR, Surewicz K, Abskharon R et al (2017) Self-propagating, protease-resistant, Recombinant prion protein conformers with or without in vivo pathogenicity. PLoS Pathog 13:e1006491","journal-title":"PLoS Pathog"},{"key":"2175_CR50","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/labinvest.3700676","volume":"87","author":"S Notari","year":"2007","unstructured":"Notari S, Capellari S, Langeveld J, Giese A, Strammiello R, Gambetti P et al (2007) A refined method for molecular typing reveals that co-occurrence of PrPSc types in Creutzfeldt\u2013Jakob disease is not the rule. Lab Investig 87:1103\u20131112","journal-title":"Lab Investig"},{"key":"2175_CR51","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(05)70225-8","volume":"4","author":"M Polymenidou","year":"2005","unstructured":"Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A (2005) Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4:805\u2013814","journal-title":"Lancet Neurol"},{"key":"2175_CR52","doi-asserted-by":"publisher","unstructured":"Wong C, Xiong L, Horiuchi M, Raymond L, Wehrly K, Chesebro B et al (2001) Sulfated glycans and elevated temperature stimulate PrPSc-dependent cell\u2010free formation of protease\u2010resistant prion protein. EMBO J [Internet]. ;20:377\u201386. Available from: http:\/\/emboj.embopress.org\/cgi\/doi\/https:\/\/doi.org\/10.1093\/emboj\/20.3.377","DOI":"10.1093\/emboj\/20.3.377"},{"key":"2175_CR53","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1128\/jvi.68.4.2135-2141.1994","volume":"68","author":"B Caughey","year":"1994","unstructured":"Caughey B, Brown K, Raymond GJ, Katzenstein GE, Thresher W (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol 68:2135\u20132141","journal-title":"J Virol"},{"key":"2175_CR54","doi-asserted-by":"publisher","first-page":"e1011083","DOI":"10.1371\/journal.ppat.1011083","volume":"19","author":"DJ Walsh","year":"2023","unstructured":"Walsh DJ, Schwind AM, Noble GP, Supattapone S (2023) Conformational diversity in purified prions produced in vitro. PLOS Pathog 19:e1011083","journal-title":"PLOS Pathog"},{"key":"2175_CR55","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1021\/bi011711s","volume":"41","author":"JA Cohlberg","year":"2002","unstructured":"Cohlberg JA, Li J, Uversky VN, Fink AL (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from \u03b1-Synuclein in vitro \u2020. Biochemistry 41:1502\u20131511","journal-title":"Biochemistry"},{"key":"2175_CR56","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1038\/s41467-022-31790-7","volume":"13","author":"Y Tao","year":"2022","unstructured":"Tao Y, Sun Y, Lv S, Xia W, Zhao K, Xu Q et al (2022) Heparin induces \u03b1-synuclein to form new fibril polymorphs with attenuated neuropathology. Nat Commun 13:4226","journal-title":"Nat Commun"},{"key":"2175_CR57","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1021\/acs.biochem.0c00443","volume":"59","author":"D Townsend","year":"2020","unstructured":"Townsend D, Fullwood NJ, Yates EA, Middleton DA (2020) Aggregation kinetics and filament structure of a Tau fragment are influenced by the sulfation pattern of the cofactor heparin. Biochemistry 59:4003\u20134014","journal-title":"Biochemistry"},{"key":"2175_CR58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","volume":"64","author":"SH Scheres","year":"2020","unstructured":"Scheres SH, Zhang W, Falcon B, Goedert M (2020) Cryo-EM structures of Tau filaments. Curr Opin Struct Biol 64:17\u201325","journal-title":"Curr Opin Struct Biol"},{"key":"2175_CR59","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, Zhang X, Kotecha A, Murzin AG et al (2022) Structures of \u03b1-synuclein filaments from human brains with lewy pathology. Nature 610:791\u2013795","journal-title":"Nature"},{"key":"2175_CR60","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0022-2836(02)00341-8","volume":"319","author":"R Gonz\u00e1lez-Iglesias","year":"2002","unstructured":"Gonz\u00e1lez-Iglesias R, Pajares MA, Ocal C, Espinosa JC, Oesch B, Gasset M (2002) Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol 319:527\u2013540","journal-title":"J Mol Biol"},{"key":"2175_CR61","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/nan.12538","volume":"45","author":"G Forloni","year":"2019","unstructured":"Forloni G, Chiesa R, Bugiani O, Salmona M, Tagliavini F (2019) Review: PrP 106-126-25 years after. Neuropathol Appl Neurobiol 45:430\u2013440","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2175_CR62","doi-asserted-by":"publisher","first-page":"9488","DOI":"10.1021\/bi1013134","volume":"49","author":"R Tycko","year":"2010","unstructured":"Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV (2010) The \u03b1-Helical C-Terminal domain of Full-Length Recombinant PrP converts to an In-Register parallel \u03b2-Sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry 49:9488\u20139497","journal-title":"Biochemistry"},{"key":"2175_CR63","doi-asserted-by":"crossref","unstructured":"M\u00fcller H, Brener O, Andreoletti O, Piechatzek T, Willbold D, Legname G et al (2014) Progress towards structural understanding of infectious sheep PrP-amyloid. Prion [Internet]. ;8:344\u201358. Available from: http:\/\/pubmed.gov\/25482596","DOI":"10.4161\/19336896.2014.983754"},{"key":"2175_CR64","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/ja106725p","volume":"133","author":"TCRG Vieira","year":"2011","unstructured":"Vieira TCRG, Reynaldo DP, Gomes MPB, Almeida MS, Cordeiro Y, Silva JL (2011) Heparin binding by murine Recombinant prion protein leads to transient aggregation and formation of RNA-Resistant species. J Am Chem Soc 133:334\u2013344","journal-title":"J Am Chem Soc"},{"key":"2175_CR65","doi-asserted-by":"crossref","unstructured":"Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol [Internet]. ;67:643\u201350. Available from: http:\/\/jvi.asm.org\/content\/67\/2\/643.short","DOI":"10.1128\/jvi.67.2.643-650.1993"},{"key":"2175_CR66","doi-asserted-by":"publisher","first-page":"17062","DOI":"10.1074\/jbc.M500122200","volume":"280","author":"L Horonchik","year":"2005","unstructured":"Horonchik L, Tzaban S, Ben-Zaken O, Yedidia Y, Rouvinski A, Papy-Garcia D et al (2005) Heparan sulfate is a cellular receptor for purified infectious Prions. J Biol Chem 280:17062\u201317067","journal-title":"J Biol Chem"},{"key":"2175_CR67","doi-asserted-by":"publisher","first-page":"40041","DOI":"10.1074\/jbc.M301152200","volume":"278","author":"O Ben-Zaken","year":"2003","unstructured":"Ben-Zaken O, Tzaban S, Tal Y, Horonchik L, Esko JD, Vlodavsky I et al (2003) Cellular Heparan sulfate participates in the metabolism of Prions. J Biol Chem 278:40041\u201340049","journal-title":"J Biol Chem"},{"key":"2175_CR68","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/exnr.1997.6740","volume":"149","author":"PA McBride","year":"1998","unstructured":"McBride PA, Wilson MI, Eikelenboom P, Tunstall A, Bruce ME (1998) Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of Scrapie-Infected mice. Exp Neurol 149:447\u2013454","journal-title":"Exp Neurol"},{"key":"2175_CR69","first-page":"601","volume":"63","author":"AD Snow","year":"1990","unstructured":"Snow AD, Wight TN, Nochlin D, Koike Y, Kimata K, DeArmond SJ et al (1990) Immunolocalization of Heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab Investig J Tech Methods Pathol 63:601\u2013611","journal-title":"Lab Investig J Tech Methods Pathol"},{"key":"2175_CR70","doi-asserted-by":"publisher","unstructured":"Adjou KT, Simoneau S, Sal\u00e8s N, Lamoury F, Dormont D, Papy-Garcia D et al (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J Gen Virol [Internet]. ;84:2595\u2013603. Available from: http:\/\/vir.sgmjournals.org\/cgi\/doi\/https:\/\/doi.org\/10.1099\/vir.0.19073-0","DOI":"10.1099\/vir.0.19073-0"},{"key":"2175_CR71","doi-asserted-by":"publisher","unstructured":"Doh-ura K, Ishikawa K, Murakami-Kubo I, Sasaki K, Mohri S, Race R et al (2004) Treatment of Transmissible Spongiform Encephalopathy by Intraventricular Drug Infusion in Animal Models. J Virol [Internet]. ;78:4999\u20135006. Available from: http:\/\/jvi.asm.org\/cgi\/doi\/https:\/\/doi.org\/10.1128\/JVI.78.10.4999-5006.2004","DOI":"10.1128\/JVI.78.10.4999-5006.2004"},{"key":"2175_CR72","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1099\/0022-1317-67-3-463","volume":"67","author":"CF Farquhar","year":"1986","unstructured":"Farquhar CF, Dickinson AG (1986) Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol. 67:463\u2013473","journal-title":"J Gen Virol"},{"key":"2175_CR73","doi-asserted-by":"publisher","unstructured":"Ladogana A, Casaccia P, Ingrosso L, Cibati M, Salvatore M, Xi Y et al (1992) Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol. 73:661\u20135. Available from: https:\/\/doi.org\/10.1099\/0022-1317-73-3-661","DOI":"10.1099\/0022-1317-73-3-661"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02175-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T14:02:53Z","timestamp":1764770573000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02175-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02175-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mouse experiments were performed at multiple research facilities: CIC bioGUNE, Centro de Biomedicina Experimental (CEBEGA) of the University of Santiago de Compostela, Neiker\u2014Basque Institute for Agricultural Research and Development, and IRTA-CReSA Animal Health Research Center. These procedures were approved by the respective institutional ethics committees with the following project codes: CIC bioGUNE (P-CBG-CBBA-0314 and 15,005\/16\/006), CEBEGA (15012\/2023\/002), Neiker (NEIKER-OEBA-2021-003), and IRTA-CReSA (5767, 11926 and 1124M2R). All experimental procedures performed until 2013 in Spain complied with the \u201cReal Decreto 1201\/2005 de 10 de Octubre\u201d and \u201cReal Decreto 214\/1997 de 30 de Julio\u201d on animal protection for experimental purposes, and those carried out from 2013 onwards complied with \u201cReal Decreto 53\/2013 de 1 de febrero\u201d on protection of animals used for experimentation and other scientific purposes, which is based on European Directive 2010\/63\/EU on Laboratory Animal Protection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Authors H.E. and J.M.C. are employed by the commercial company ATLAS Molecular Pharma SL. This does not alter our adherence to the Journal\u2019s policies on sharing data and materials and did not influence in any way the work reported in this manuscript, given that the company had no role in study design, funding, and data analysis. The rest of the authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}